Incentives and Anchoring to Improve Long-term HIV Medication Adherence
Official title: INcentives and ReMINDers to Improve Long-term Medication Adherence (INMIND)
Funded at Rand Corporation · NIH-11590750 · Data updated 2026-11-12
A study tests a simple, daily habit plan combined with friendly reminders and small rewards to help people living with HIV take their ART pills on time.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rand Corporation NIH-funded |
| Lab location | 1 site (Santa Monica, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $94,805 |
| NIH project number | 3R01MH135751-03S1 |
| Project ID | NIH-11590750 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults living with HIV who are starting or continuing ART and are willing to engage with an anchoring plan and receive text reminders and potential incentives.
✕Less likely to help
Patients who do not respond to reminders or do not engage with the anchoring plan may not see benefit.
What this research studies
This project builds on a plan to pair ART taking with an existing daily routine, using daily text reminders and small monthly prizes to boost adherence. It uses behavioral economics ideas to make sticking to the plan easier over three months and beyond. The goal is to help people with HIV maintain high pill-taking consistency so that their viral load stays suppressed. The research is conducted with adults at RAND Corporation, focusing on those who are starting or continuing ART.
Why it matters
Potential benefit: If successful, this approach could make it easier for people living with HIV to stay adherent to ART, improving viral suppression and health outcomes.
How similar studies have gone: Previous anchoring approaches showed promise but often lacked ongoing support; this study adds reminders and incentives to sustain behavior.
Where this research is happening
-
Rand Corporation
Santa Monica, United States Active
Researchers
- Principal investigator: Linnemayr, Sebastian — Rand Corporation
- Study coordinator: Linnemayr, Sebastian
Related research
Other NIH-funded projects on the same topics.
-
Understanding why patients with blood cancers start and stick with oral cancer medicines
A study to learn what helps or hinders Black patients with blood cancers in starting and continuing their prescribed oral cancer medicines.
-
WeCare: a combined mental health and HIV medication support program for high-risk men
A patient-friendly program called WeCare aims to support mental health and improve adherence to HIV meds among high-risk men in settings with limited resources.
-
Medication adherence to epilepsy medicines during pregnancy and related birth outcomes
This project looks at how well pregnant people with epilepsy take their anti-seizure medicines and what happens to their babies.
-
Adaptive mHealth Support to Help Teens with Asthma Stick to Their Inhalers
A multi-site study tests a flexible smartphone-based program to help adolescents with asthma take their inhaled meds more consistently.
-
Reducing High Blood Pressure in Men in Manual Jobs with a Mobile Stress and Medication Adherence Program
A mobile stress-management and medication adherence program aims to help men in manual and trade jobs lower their blood pressure and stay on their prescribed treatment.
-
Pharmacy-Integrated AI System to Help AD/ADRD Patients Take Meds and Stay Out of the Hospital
A new AI-powered home medication system helps people with Alzheimer’s and related dementias take their medicines correctly to reduce hospital visits and ease caregiving.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.